Principia Biopharma Inc (PRNB) Return on Assets ROA from the second quarter of 2020 to second quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Jun 30 2020 to Jun 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Principia Biopharma Inc   (NASDAQ: PRNB)


Principia Biopharma Inc 's ROA from the second quarter of 2020 to the second quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Principia Biopharma Inc 's ROA in the second quarter of 2020?
Principia Biopharma Inc recorded a cumulative net loss of $-15 million during 12 months ending in the second quarter of 2020, resulting in a negative return on assets (ROA) of -4.63%.

However, within the Healthcare sector 226 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2020 quarter, so far to 2993, from total ROA ranking in the first quarter of 2020 at 3254.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Total Assets Change 100.39 % 103.09 % 95.75 % -13.21 % 324.88 %
Y / Y Net Income Change 51.93 % - 207.86 % - 295.94 %
Net Income (TTM) in million -15 -19 0 -19 9
Return On Assets (TTM) -4.63 % -6.77 % 0 % -10.53 % 4.95 %
PRNB's Total Ranking # 2993 # 3254 # # 3594 # 1324
Total Assets (TTM) in million 385 363 383 174 192
Seq. Total Assets Change 6.24 % -5.22 % 119.85 % -9.49 % 7.67 %
Seq. Net Income Change - - - - -

PRNB's 5 Years Annual ROA >> Back to PRNB Management Effectiveness >> Compare PRNB ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 72
Sector # 227
Overall # 2895

Return On Assets Statistics
High Average Low
4.95 %
-2.86 %
-10.53 %
(Jun 30 2019)   (Sep 30 2019)





Financial Statements
Principia Biopharma Inc 's Assets $ 385 million PRNB's Balance sheet
Principia Biopharma Inc 's Income $ 11 million Quarterly PRNB's Income Statement
PRNB's Income by Division See PRNB's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
FY
FY
FY
Y / Y Total Assets Change 95.75 % - - - -
Total Assets in million 383 196 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million 0 18 0 0 0
Annual Return On Assets 0 % 9.29 % - - -

PRNB's 5 Years Annual ROA >> Back to PRNB Management Effectiveness >> Compare PRNB ROA to its Competitors



More Return On Assets Ratios
PRNB's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PRNB's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PRNB's Competitors
Subscribers only: Roa for Principia Biopharma Inc 's Suppliers
Subscribers only: Return On Assets for PRNB's Customers

You may also want to know
PRNB's Roi PRNB's Inventory Turnover Ratio PRNB's Growth Rates PRNB's Dividend Comparisons
PRNB's Profitability Ratios PRNB's Asset Turnover Ratio PRNB's Dividend Growth
PRNB's Roe PRNB's Valuation Ratios PRNB's Financial Strength Ratios PRNB's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2020, within Healthcare Sector ROA

Date modified: 2026-10-07T00:41:43+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.